Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Cell Mol Neurobiol ; 33(2): 253-60, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23232760

RESUMO

Phenylketonuria (PKU) is an inherited metabolic disorder caused by deficiency of phenylalanine hydroxylase which leads to accumulation of phenylalanine and its metabolites in tissues of patients with severe neurological involvement. Recently, many studies in animal models or patients have reported the role of oxidative stress in PKU. In the present work we studied the effect of lipoic acid against oxidative stress in rat brain provoked by an animal model of hyperphenylalaninemia (HPA), induced by repetitive injections of phenylalanine and α-methylphenylalanine (a phenylalanine hydroxylase inhibitor) for 7 days, on some oxidative stress parameters. Lipoic acid prevented alterations on catalase (CAT) and superoxide dismutase (SOD), and the oxidative damage of lipids, proteins, and DNA observed in HPA rats. In addition, lipoic acid diminished reactive species generation compared to HPA group which was positively correlated to SOD/CAT ratio. We also observed that in vitro Phe inhibited CAT activity while phenyllactic and phenylacetic acids stimulated superoxide dismutase activity. These results demonstrate the efficacy of lipoic acid to prevent oxidative stress induced by HPA model in rats. The possible benefits of lipoic acid administration to PKU patients should be considered.


Assuntos
Encéfalo/enzimologia , Catalase/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Fenilcetonúrias/enzimologia , Fenilcetonúrias/patologia , Superóxido Dismutase/metabolismo , Ácido Tióctico/farmacologia , Animais , Encéfalo/efeitos dos fármacos , Encéfalo/patologia , Dano ao DNA , Modelos Animais de Doenças , Inibidores Enzimáticos/farmacologia , Feminino , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Fenilalanina/administração & dosagem , Fenilalanina/farmacologia , Fenilalanina Hidroxilase/antagonistas & inibidores , Fenilalanina Hidroxilase/metabolismo , Fenilcetonúrias/tratamento farmacológico , Ratos , Ratos Wistar , Ácido Tióctico/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA